Dr. Kaleb Yohay, MD
Claim this profileNew York University Langone Medical Center
Affiliated Hospitals
New York University Langone Medical Center
New York University Medical Center
Clinical Trials Kaleb Yohay, MD is currently running
Targeted Therapy
for Neurofibromatosis
This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow people with multiple tumor types associated with NF2-SWN to receive new drugs throughout this study. Embedded within the Master Study are individual drug substudies. * Investigational Drug Sub-study A: Brigatinib * Investigational Drug Sub-study B: Neratinib * Investigational Drug Sub-study C: Retifanlimab plus bevacizumab
Recruiting
1 award
Phase 2
18 criteria
Combination Therapy
for Sarcoma
This trial tests a combination of three drugs to treat adults with hard-to-treat sarcomas, especially a type called MPNST linked to NF1. The drugs work together to stop cancer growth and boost the immune system. The study aims to find out if this combination is safe and effective. The combination of panobinostat, venetoclax, and anti-CD40 has shown promise in preclinical models for inducing complete tumor remission.
Recruiting
1 award
Phase 2
More about Kaleb Yohay, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kaleb Yohay, MD has experience with
- Brigatinib
- Neratinib
- Selumetinib
Breakdown of trials Kaleb Yohay, MD has run
Cerebellopontine Angle Tumor
Gamma Knife Treatment
Clear Cell Ependymoma
Acoustic neuroma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kaleb Yohay, MD specialize in?
Kaleb Yohay, MD focuses on Neurofibromatosis and Cerebellopontine Angle Tumor. In particular, much of their work with Neurofibromatosis has involved NF2 positive patients, or patients who are undergoing treatment.
Is Kaleb Yohay, MD currently recruiting for clinical trials?
Yes, Kaleb Yohay, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Kaleb Yohay, MD has studied deeply?
Yes, Kaleb Yohay, MD has studied treatments such as Brigatinib, Neratinib, Selumetinib.
What is the best way to schedule an appointment with Kaleb Yohay, MD?
Apply for one of the trials that Kaleb Yohay, MD is conducting.
What is the office address of Kaleb Yohay, MD?
The office of Kaleb Yohay, MD is located at: New York University Langone Medical Center, New York, New York 10016 United States. This is the address for their practice at the New York University Langone Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.